Optimize the Effectiveness of Pharma Patient Adherence and Disease Management Programs With Market Research
Posted on: Tuesday, 31 October 2006, 09:01 CST
RESEARCH TRIANGLE PARK, N.C., Oct. 31 /PRNewswire/ -- Pharmaceutical companies that perform market research are able to base their patient adherence and disease management programs on a solid understanding of patients' needs and preferences. According to "Pharmaceutical Patient Adherence and Disease Management," available at (http://www.pharmapatientadherence.com/), this research is central in creating meaningful messages and connecting with target audiences through their preferred media channels.
"Companies that develop these programs from a patient-centric perspective experience the best outcomes," said Amanda Zuniga, research analyst at Cutting Edge Information and lead author of the report. "Performing market research and integrating the findings into program design should be one of the first steps companies make when building an effective patient adherence/disease management program."
The study found that the average company invests 22% of its program's development budget to perform market research. Nonetheless, many program teams also rely on the company's existing market research to help tailor their programs. Achieving patient buy-in, which is critical to program success, requires program teams to understand and address what drives patients' non- adherent behavior, what factors affect patients' decisions, and which media channels patients trust and prefer.
Integrating market research knowledge into campaign design will help companies develop customized messages that are influential and meaningful to patients. Customization is one of the most important aspects of an effective campaign. Even the most resource-rich initiative will fail to see positive results if it does not connect with patients and achieve their buy-in. Market research is one tool that, if used properly, can help companies overcome the challenge of providing customized messages.
"Pharmaceutical Patient Adherence and Disease Management: Program Development, Management and Improvement," available at http://www.pharmapatientadherence.com/, contains budget and staffing metrics for 18 different patient adherence/disease management programs. Budget benchmarks include cost to attain a new patient versus cost to retain an existing patient, annual program maintenance budgets, outsourced budgets, and specific activity budget breakdowns. Case studies, best practices and tactics for addressing key program challenges are utilized to give executives a guide to managing their own programs with success.
To view a summary of "Pharmaceutical Patient Adherence and Disease Management: Program Development, Management and Improvement," visit http://www.pharmapatientadherence.com/ or contact Amanda Zuniga at Amanda_Zuniga@cuttingedgeinfo.com or 919-433-0210.
Cutting Edge Information
CONTACT: Amanda Zuniga of Cutting Edge Information,Amanda_Zuniga@cuttingedgeinfo.com, or +1-919-433-0210
Web site: http://www.cuttingedgeinfo.com/http://www.pharmapatientadherence.com/
Source: PRNewswire
Related Articles
- The Risk Management and Patient Safety Institute Announces Winter and Spring 2009 Audio Program Lineup, Annual Conference Dates
- Two-Thirds of Healthcare Professionals Polled Attribute Improved Patient Self-Management to the U.S. Diabetes Conversation Map(R) Program
- Valeant Pharmaceuticals Announces the Launch of the zelaCARD for Parkinson's Disease Patients Taking Zelapar(R)
- Disease Management and Patient Adherence: 41% of Program Budgets Are Outsourced
- St. Jude Medical Announces Agreement With LUMEDX To Manage Cardiovascular Patient Data
- PBT2 Phase IIa Clinical Trial in Alzheimer's Disease Patients
- Covalent Group, Inc. Signs $2.2 Million Contract With New Sponsor to Conduct Clinical Trial in Patients With Cardiovascular Disease
- New Blood Test for Management of Osteoporosis Cleared By the FDA; Roche Diagnostics' Test Aids Physicians and Patients in Monitoring Disease
- APhA Foundation Announces Recipients of the Incentive Grants Focused on Serving Patients With Alzheimer's Disease and Dementia
- Roche and GE Healthcare to Explore Personalized Medicine in Patients With Alzheimer's Disease
 |
 |
User Comments (0)
RSS Feeds